• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对未经手术切除的原发性和复发性翼状胬肉进行锶-90/钇-90β射线单纯照射的前瞻性研究。长期随访的临床结果。

Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.

作者信息

Vastardis Iraklis, Pajic Bojan, Greiner Richard H, Pajic-Eggspuehler Brigitte, Aebersold Daniel M

机构信息

Ophthalmology Clinic Pallas, Olten, Switzerland.

出版信息

Strahlenther Onkol. 2009 Dec;185(12):808-14. doi: 10.1007/s00066-009-2000-1.

DOI:10.1007/s00066-009-2000-1
PMID:20013090
Abstract

PURPOSE

To evaluate the consecutive treatment results regarding pterygium recurrence and the efficacy of exclusive strontium-/yttrium-90 beta-irradiation for primary and recurrent pterygia and to analyze the functional outcome.

PATIENTS AND METHODS

Between October 1974 and December 2005, 58 primary and 21 recurrent pterygia were exclusively treated with strontium-/yttrium-90 beta-irradiation with doses ranging from 3,600 to 5,500 cGy. The follow-up time was 46.6 +/- 26.7 months, with a median of 46.5 months.

RESULTS

The treatment led to a size reduction in all pterygia (p < 0.0001). Neither recurrences nor side effects were observed during therapy and follow-up in this study. Best-corrected visual acuity increased (p = 0.0064). Corneal astigmatism was reduced in recurrent pterygia (p = 0.009).

CONCLUSION

Exclusive strontium-/yttrium-90 beta-irradiation of pterygia is a very efficient and well-tolerated treatment, with remarkable aesthetic and rehabilitative results in comparison to conventional treatments, especially for recurrent lesions which have undergone prior surgical excision.

摘要

目的

评估翼状胬肉复发的连续治疗结果以及锶 - /钇 - 90β射线单独照射治疗原发性和复发性翼状胬肉的疗效,并分析功能结局。

患者与方法

1974年10月至2005年12月期间,58例原发性翼状胬肉和21例复发性翼状胬肉接受了剂量范围为3600至5500厘戈瑞的锶 - /钇 - 90β射线单独照射。随访时间为46.6±26.7个月,中位数为46.5个月。

结果

治疗使所有翼状胬肉的大小减小(p < 0.0001)。在本研究的治疗和随访期间,未观察到复发或副作用。最佳矫正视力提高(p = 0.0064)。复发性翼状胬肉的角膜散光减少(p = 0.009)。

结论

翼状胬肉的锶 - /钇 - 90β射线单独照射是一种非常有效且耐受性良好的治疗方法,与传统治疗相比,具有显著的美学和康复效果,特别是对于先前已接受手术切除的复发性病变。

相似文献

1
Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.对未经手术切除的原发性和复发性翼状胬肉进行锶-90/钇-90β射线单纯照射的前瞻性研究。长期随访的临床结果。
Strahlenther Onkol. 2009 Dec;185(12):808-14. doi: 10.1007/s00066-009-2000-1.
2
Prospective study on exclusive, nonsurgical strontium-/yttrium-90 irradiation of pterygia.翼状胬肉锶-90/钇-90单纯非手术照射的前瞻性研究
Strahlenther Onkol. 2004 Aug;180(8):510-6. doi: 10.1007/s00066-004-1230-5.
3
Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia.翼状胬肉非手术、单纯锶-90/钇-90β射线照射的长期结果
Radiother Oncol. 2005 Jan;74(1):25-9. doi: 10.1016/j.radonc.2004.08.022.
4
Low-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study.低剂量锶-90 照射在预防翼状胬肉复发中的作用:一项十年研究。
PLoS One. 2012;7(8):e43500. doi: 10.1371/journal.pone.0043500. Epub 2012 Aug 27.
5
Pterygium treated with excision and postoperative beta irradiation.
Int J Radiat Oncol Biol Phys. 1992;23(3):533-7. doi: 10.1016/0360-3016(92)90008-6.
6
Evaluation of the effectiveness of post-operative beta-irradiation in the management of pterygium.术后β射线照射治疗翼状胬肉的疗效评估
Afr J Med Med Sci. 2002 Mar;31(1):9-11.
7
Changes of Corneal Biomechanical Properties upon Exclusive Ytt-/Sr-90 Irradiation of Pterygium.翼状胬肉单独接受 Yttrium-90/Strontium-90 射线照射后角膜生物力学特性的变化。
Sensors (Basel). 2021 Feb 2;21(3):975. doi: 10.3390/s21030975.
8
[Results of strontium-yttrium-90 for pterygia].
J Fr Ophtalmol. 2002 May;25(5):473-9.
9
Recurrent pterygia: results of postoperative treatment with Sr-90 applicators.
Radiology. 1990 Feb;174(2):565-6. doi: 10.1148/radiology.174.2.2296667.
10
Comparative efficacy of beta-irradiation and mitomycin-C in primary and recurrent pterygium.β射线照射与丝裂霉素C治疗原发性及复发性翼状胬肉的疗效比较
Eur J Ophthalmol. 2001 Apr-Jun;11(2):126-32. doi: 10.1177/112067210101100204.

引用本文的文献

1
Changes of Corneal Biomechanical Properties upon Exclusive Ytt-/Sr-90 Irradiation of Pterygium.翼状胬肉单独接受 Yttrium-90/Strontium-90 射线照射后角膜生物力学特性的变化。
Sensors (Basel). 2021 Feb 2;21(3):975. doi: 10.3390/s21030975.
2
Biomechanical Modeling of Pterygium Radiation Surgery: A Retrospective Case Study.翼状胬肉放射外科的生物力学建模:一项回顾性病例研究。
Sensors (Basel). 2017 May 24;17(6):1200. doi: 10.3390/s17061200.
3
Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.

本文引用的文献

1
Ethical and legal reasons why radiation treatment should be preapproved by informed consent.放射治疗应通过知情同意预先批准的伦理和法律原因。
Strahlenther Onkol. 2008 Aug;184(8):429-30. doi: 10.1007/s00066-008-9757-5.
2
Long-term results and prognostic factors of fractionated strontium-90 eye applicator for pterygium.
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1174-9. doi: 10.1016/j.ijrobp.2008.02.075. Epub 2008 Jul 14.
3
Prospective study of primary pterygium surgery using pterygium extended removal followed by extended conjunctival transplantation.采用翼状胬肉扩大切除术联合结膜扩大移植术治疗原发性翼状胬肉的前瞻性研究。
包括近距离放射治疗在内的前瞻性临床试验组合:对ClinicalTrials.gov数据库的分析
Radiat Oncol. 2016 Mar 22;11:48. doi: 10.1186/s13014-016-0624-8.
4
Reirradiation of spinal column metastases: comparison of several treatment techniques and dosimetric validation for the use of VMAT.脊柱转移瘤再放疗:比较几种治疗技术和剂量学验证,以评估 VMAT 的应用。
Strahlenther Onkol. 2011 Jul;187(7):406-15. doi: 10.1007/s00066-011-2198-6. Epub 2011 Jun 27.
5
[The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH)].[放射治疗对有症状椎体血管瘤(SVH)的意义]
Strahlenther Onkol. 2010 Aug;186(8):430-5. doi: 10.1007/s00066-010-2140-3. Epub 2010 Jul 29.
6
[Pterygium. Etiology, clinical aspects and novel adjuvant therapies].[翼状胬肉。病因、临床特征及新型辅助治疗]
Ophthalmologe. 2010 Jun;107(6):517-20, 522-4. doi: 10.1007/s00347-009-2100-4.
Ophthalmology. 2008 Oct;115(10):1663-72. doi: 10.1016/j.ophtha.2008.03.012. Epub 2008 Jun 16.
4
Analysis of pterygium size and induced corneal astigmatism.翼状胬肉大小及诱导性角膜散光分析。
Cornea. 2008 May;27(4):434-8. doi: 10.1097/ICO.0b013e3181656448.
5
Effect of pterygium surgery on corneal topography.翼状胬肉手术对角膜地形图的影响。
Eur J Ophthalmol. 2008 Mar-Apr;18(2):177-81. doi: 10.1177/112067210801800203.
6
The anti-inflammatory effect of low-dose radiation therapy involves a diminished CCL20 chemokine expression and granulocyte/endothelial cell adhesion.低剂量放射治疗的抗炎作用涉及CCL20趋化因子表达减少以及粒细胞/内皮细胞黏附减少。
Strahlenther Onkol. 2008 Jan;184(1):41-7. doi: 10.1007/s00066-008-1776-8.
7
Current concepts and techniques in pterygium treatment.翼状胬肉治疗的当前概念与技术
Curr Opin Ophthalmol. 2007 Jul;18(4):308-13. doi: 10.1097/ICU.0b013e3281a7ecbb.
8
Curative brachytherapy for recurrent/residual tongue cancer.
Strahlenther Onkol. 2007 Mar;183(3):133-7. doi: 10.1007/s00066-007-1613-5.
9
Radiotherapy for orbital lymphoma : outcome and late effects.眼眶淋巴瘤的放射治疗:疗效与晚期效应
Strahlenther Onkol. 2007 Jan;183(1):17-22. doi: 10.1007/s00066-007-1627-z.
10
Estimation of cancer risks from radiotherapy of benign diseases.良性疾病放射治疗的癌症风险评估。
Strahlenther Onkol. 2006 Aug;182(8):431-6. doi: 10.1007/s00066-006-1542-8.